Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Saved in:
| Title: | Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. |
|---|---|
| Authors: | Krämer A; Clinical Cooperation Unit Molecular Haematology/Oncology, German Cancer Research Center (DKFZ) Heidelberg, Germany; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany., Bochtler T; Clinical Cooperation Unit Molecular Haematology/Oncology, German Cancer Research Center (DKFZ) Heidelberg, Germany; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany; Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Heidelberg, Germany., Pauli C; Department of Pathology and Molecular Pathology, University Hospital Zurich (USZ), Zurich, Switzerland; Medical Faculty, University of Zurich (UZH), Zurich, Switzerland., Baciarello G; Medical Oncology Department, Azienda Ospedaliera San Camillo Forlanini, Rome, Italy., Delorme S; Division of Radiology, German Cancer Research Center (DKFZ), Heidelberg., Hemminki K; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and Biomedical Center, Charles University, Pilsen, Czech Republic., Mileshkin L; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia., Moch H; Department of Pathology and Molecular Pathology, University Hospital Zurich (USZ), Zurich, Switzerland; Medical Faculty, University of Zurich (UZH), Zurich, Switzerland., Oien K; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK., Olivier T; Department of Oncology, Geneva University Hospital, Geneva, Switzerland; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, USA., Patrikidou A; Department of Cancer Medicine, Institute Gustave Roussy, University of Paris Saclay, Villejuif, France., Wasan H; Department of Cancer Medicine, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK., Zarkavelis G; Department of Medical Oncology, University of Ioannina, Ioannina, Greece., Pentheroudakis G; European Society for Medical Oncology, Lugano, Switzerland., Fizazi K; Department of Cancer Medicine, Institute Gustave Roussy, University of Paris Saclay, Villejuif, France. |
| Corporate Authors: | ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org |
| Source: | Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2023 Mar; Vol. 34 (3), pp. 228-246. Date of Electronic Publication: 2022 Dec 20. |
| Publication Type: | Practice Guideline; Research Support, Non-U.S. Gov't; Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
